Back
Day Range
$22.25
$23.10
52-Week Range
$13.74
$70.43
Volume
18,903,675
50D / 200D Avg
$23.15
/
$41.39
Prev Close
$22.02
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (625 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 38.4 | 14.0 |
| P/B | 9.1 | 2.4 |
| ROE % | 25.2 | 11.4 |
| Net Margin % | 5.5 | 10.1 |
| Rev Growth 5Y % | 71.4 | 7.0 |
| D/E | 2.3 | 0.5 |
Key Takeaways
Revenue grew 71.42% annually over 5 years — strong growth
ROE of 25.23% indicates high profitability
Debt/Equity of 2.34 — high leverage
Generating 73.96M in free cash flow
P/E of 38.42 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 12.42%
Growth
Revenue Growth (5Y)
71.42%
Revenue (1Y)59.00%
Earnings (1Y)1.85%
FCF Growth (3Y)25.46%
Quality
Return on Equity
25.23%
ROIC5.06%
Net Margin5.47%
Op. Margin5.18%
Safety
Debt / Equity
2.34
Current Ratio1.90
Interest Coverage0.00
Valuation
P/E Ratio
38.42
P/B Ratio9.12
EV/EBITDA49.03
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 59.00% | Revenue Growth (3Y) | 64.08% |
| Earnings Growth (1Y) | 1.85% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 71.42% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2.35B | Net Income (TTM) | 128.37M |
| ROE | 25.23% | ROA | 5.96% |
| Gross Margin | 59.31% | Operating Margin | 5.18% |
| Net Margin | 5.47% | Free Cash Flow (TTM) | 73.96M |
| ROIC | 5.06% | FCF Growth (3Y) | 25.46% |
| Safety | |||
| Debt / Equity | 2.34 | Current Ratio | 1.90 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 38.42 | P/B Ratio | 9.12 |
| P/S Ratio | 2.10 | PEG Ratio | -33.00 |
| EV/EBITDA | 49.03 | Dividend Yield | 0.00% |
| Market Cap | 4.93B | Enterprise Value | 5.97B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.35B | 1.48B | 872.00M | 526.92M | 271.88M |
| Net Income | 128.37M | 126.04M | -23.55M | -65.68M | -107.66M |
| EPS (Diluted) | 0.51 | 0.53 | -0.11 | -0.32 | -0.58 |
| Gross Profit | 1.39B | 1.17B | 714.95M | 408.72M | 204.49M |
| Operating Income | 121.69M | 61.90M | -29.45M | -68.70M | -115.04M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.15B | 707.54M | 441.19M | 366.34M | 420.59M |
| Total Liabilities | 1.61B | 230.82M | 97.16M | 54.60M | 85.97M |
| Shareholders' Equity | 540.93M | 476.72M | 344.03M | 311.74M | 334.62M |
| Total Debt | 1.26B | 11.35M | 9.95M | 5.31M | 5.48M |
| Cash & Equivalents | 228.62M | 220.58M | 96.66M | 46.77M | 71.78M |
| Current Assets | 767.64M | 395.83M | 265.05M | 216.60M | 269.91M |
| Current Liabilities | 404.43M | 221.37M | 88.47M | 47.94M | 79.22M |